Imaging appearances following thermal ablation

Clinical Radiology

Volumn 63, Issue 1, 2008, Pages 1-11

  Smith, S ^a   Gillams, A ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; IMAGING; LIVER ABSCESS; LIVER TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SOLID TUMOR; ULTRASOUND;

AGED; CATHETER ABLATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; TOMOGRAPHY, X-RAY COMPUTED;

EID: 36749053462     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2007.06.002     Document Type: Review

References (48)

1. Livraghi T., Solbiati L., Meloni M.F., et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226 (2003) 441-451
2. Yasui K., and Shimizu Y. Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol 10 (2005) 86-96
3. Livraghi T., Sangalli G., and Vettori C. Adenomatous hyperplastic nodules in the cirrhotic liver: a therapeutic approach. Work in progress. Radiology 170 (1989) 155-157
4. Steger A.C., Lees W.R., Walmsley K., et al. Interstitial laser hyperthermia: a new approach to local destruction of tumours. BMJ 299 (1989) 362-365
5. McGahan J.P., Browning P.D., Brock J.M., et al. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 25 (1990) 267-270
6. Rossi S., Fornari F., Pathies C., et al. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori 76 (1990) 54-57
7. Gillams A.R. The use of radiofrequency in cancer. Br J Cancer 92 (2005) 1825-1829
8. Solbiati L., Livraghi T., Goldberg S.N., et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221 (2001) 159-166
9. Gillams A.R., and Lees W.R. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14 (2004) 2261-2267
10. Gillams A.R., and Lees W.R. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 43 (2000) 656-661
11. Jakobs T.F., Hoffmann R.T., Trumm C., et al. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res 26 (2006) 671-680
12. Livraghi T., Goldberg S.N., Solbiati L., et al. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 220 (2001) 145-149
13. Lawes D., Chopada A., Gillams A., et al. Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer. Ann R Coll Surg Engl 88 (2006) 639-642
14. Gillams A., Cassoni A., Conway G., et al. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 30 (2005) 435-441
15. Ni Y., Mulier S., Miao Y., et al. A review of the general aspects of radiofrequency ablation. Abdom Imaging 30 (2005) 381-400
16. Goldberg S.N., Gazelle G.S., Compton C.C., et al. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer 88 (2000) 2452-2463
17. Hansen P.D., Rogers S., Corless C.L., et al. Radiofrequency ablation lesions in a pig liver model. J Surg Res 87 (1999) 114-121
18. Raman S.S., Lu D.S., Vodopich D.J., et al. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol 175 (2000) 1253-1258
19. Vilana R., Llovet J.M., Bianchi L., et al. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. J Clin Ultrasound 31 (2003) 119-128
20. Wen Y.L., Kudo M., Zheng R.Q., et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol 181 (2003) 57-63
21. Choi D., Lim H.K., Rhim H., et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol (2007)
22. Gillams A., and Lees W.R. Thermal ablation induced changes in hepatic arterial perfusion. Radiology (1999) 213P
23. Tsuda M., Majima K., Yamada T., et al. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin Imaging 25 (2001) 409-415
24. Nghiem H.V., Francis I.R., Fontana R., et al. Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy. Curr Probl Diagn Radiol 31 (2002) 105-111
25. Choi H., Loyer E.M., DuBrow R.A., et al. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. RadioGraphics 21 (2001) S41-S54
26. Berber E., Foroutani A., Garland A.M., et al. Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc 14 (2000) 799-804
27. Chopra S., Dodd III G.D., Chintapalli K.N., et al. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol 177 (2001) 381-387
28. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 (2000) 205-216
29. Dromain C., de Baere T., Elias D., et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology 223 (2002) 255-262
30. Gillams A.R. Complications of percutaneous therapy. Cancer Imaging 5 (2005) 110-113
31. Veit P., Antoch G., Stergar H., et al. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 16 (2006) 80-87
32. Donckier V., Van Laethem J.L., Goldman S., et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 84 (2003) 215-223
33. Yamamoto A., Nakamura K., Matsuoka T., et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. AJR Am J Roentgenol 185 (2005) 1299-1306
34. Rossi S., Dore R., Cascina A., et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 27 (2006) 556-563
35. Steinke K., King J., Glenn D., et al. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 27 (2003) 750-757
36. Bojarski J.D., Dupuy D.E., and Mayo-Smith W.W. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 185 (2005) 466-471
37. Oyama Y., Nakamura K., Matsuoka T., et al. Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology. Cardiovasc Intervent Radiol 28 (2005) 346-353
38. Okuma T., Matsuoka T., Okamura T., et al. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47 (2006) 1351-1358
39. Okuma T., Okamura T., Matsuoka T., et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med 20 (2006) 115-121
40. Akeboshi M., Yamakado K., Nakatsuka A., et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 15 (2004) 463-470
41. Crowley J.D., Shelton J., Iverson A.J., et al. Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue: acute and chronic effects in an animal model. Urology 57 (2001) 976-980
42. Zagoria R.J., Hawkins A.D., Clark P.E., et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol 183 (2004) 201-207
43. Arzola J., Baughman S.M., Hernandez J., et al. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology 68 (2006) 983-987
44. Roy-Choudhury S.H., Cast J.E., Cooksey G., et al. Early experience with percutaneous radiofrequency ablation of small solid renal masses. AJR Am J Roentgenol 180 (2003) 1055-1061
45. Ogan K., Jacomides L., Dolmatch B.L., et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology 60 (2002) 954-958
46. Gervais D.A., McGovern F.J., Arellano R.S., et al. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226 (2003) 417-424
47. Svatek R.S., Sims R., Anderson J.K., et al. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation. Urology 67 (2006) 508-512
48. Sironi S., Livraghi T., Meloni F., et al. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol 173 (1999) 1225-1229